UK Government Approved Travel Testing Package for Testing on Day 2 and 8. Discover More.
-
Shop
-
Goal
-
Learn
-
Enterprise
The team behind the technology
Project Screen by Prenetics is an initiative developed by Prenetics, a healthcare company with headquarters in London and Hong Kong.
Read More
Prenetics leadership team
Danny Yeung
Group CEO (Co-founder) Prenetics/ CircleDNA
Avi Lasarow
CEO Prenetics EMEA & DNAfit, Hon. Consul South Africa to UK
Andrew Steele
Head of Product Prenetics EMEA & DNAfit
Rio Ferdinand
Subject Expert/ Player Engagement Prenetics EMEA & DNAfit
Brian Stephenson
Head of Operations, Prenetics EMEA & DNAfit
Jotika Behari
Data Information Security, Prenetics EMEA & DNAfit
Dereck Chisora
Subject Expert/ Player Engagement Prenetics EMEA & DNAfit
Prenetics’ expert scientific consortium
Dr. Rachel Liebmann
Group Medical Director, The Doctor’s Laboratory and Vice President of the Royal College of Pathologists
Dr. Mark Atkin
Consultant Virologist, The Doctor’s Laboratory
Dr. Senthil Sundaram, MD
Chief Clinical Officer at Prenetics; Leads clinical development of molecular genetic testing
Dr. Lawrence Tzang CH, BSc, PhD, Reg MLT
Chief Scientific Officer & Laboratory Director of Prenetics COVID-19 Screening Facility
Scientific working group
Prof. Alan McNally, BSC, PhD
Director of Institute of Microbiology and Infection, University of Birmingham
Prof. Willem Van Schaik, MSc, PhD
Institute of Microbiology and infection, University of Birmingham
Prof. Michael M Yang, PhD
Head and Chair Professor, Department of Biomedical Sciences at City University of Hong Kong
Dr. Richard H. Kaszynski, M.A, M.D,PhD
Co-Founder: Stanford Solutions, a healthcare innovation group founded out of Standard University School of Medicine. Executive Director, Shinwakai Medical Group, Tokyo, Japan
